Preparation and characterization of monoclonal antibodies recognizing two CD4 isotypes of Microminipigs.
Amino Acid Sequence
Animals
Antibodies, Monoclonal
/ immunology
Antibody Specificity
CD4 Antigens
/ analysis
CD8 Antigens
/ analysis
Cell Line, Tumor
Female
Genotype
HEK293 Cells
Histocompatibility Antigens Class I
/ genetics
Humans
Leukocytes, Mononuclear
/ immunology
Lymphocyte Activation
Male
Mice
Mice, Inbred BALB C
Models, Molecular
Protein Conformation
Sequence Alignment
Sequence Homology, Amino Acid
Specific Pathogen-Free Organisms
Swine
Swine, Miniature
/ genetics
Transfection
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
05
2020
accepted:
04
11
2020
entrez:
25
11
2020
pubmed:
26
11
2020
medline:
5
1
2021
Statut:
epublish
Résumé
Cluster of differentiation 4 (CD4) molecule expressed on the leukocytes is known to function as a co-receptor for class II major histocompatibility complex (MHC) binding to T cell receptor (TCR) on helper T cells. We previously identified two CD4 alleles (CD4.A and CD4.B) in a Microminipig population based on nucleotide sequencing and PCR detection of their gene sequences. However, CD4.B protein expression was not examined because of the unavailability of a reactive antibody to a CD4.B epitope. In this study, we have produced two swine-specific monoclonal antibodies (mAbs) against CD4.B molecules, one that recognizes only CD4.B (b1D7) and the other that recognizes both the CD4.A and CD4.B alleles (x1E10) and that can be used to distinguish CD4 T cell subsets by flow cytometry and immunohistochemistry. Using these two mAbs, we identified CD4.A and CD4.B allele-specific proteins on the surface of CD4.A (+/+) and CD4.B (+/+) T cells at a similar level of expression. Moreover, stimulation of peripheral blood mononuclear cells (PBMCs) derived from CD4.A (+/+) and CD4.B (+/+) swine with toxic shock syndrome toxin-1 (TSST-1) in vitro similarly activated both groups of cells that exhibited a slight increase in the CD4/CD8 double positive (DP) cell ratio. A large portion of the DP cells from the allelic CD4.A (+/+) and CD4.B (+/+) groups enhanced the total CD4 and class I swine leukocyte antigen (SLA) expression. The x1E10 mAb delayed and reduced the TSST-1-induced activation of CD4 T cells. Thus, CD4.B appears to be a functional protein whose expression on activated T cells is analogous to CD4.A.
Identifiants
pubmed: 33237936
doi: 10.1371/journal.pone.0242572
pii: PONE-D-20-14895
pmc: PMC7688132
doi:
Substances chimiques
Antibodies, Monoclonal
0
CD4 Antigens
0
CD8 Antigens
0
Histocompatibility Antigens Class I
0
swine leukocyte antigen
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0242572Déclaration de conflit d'intérêts
Thee authors have declared that no competing interests exist.
Références
Biochemistry. 2006 May 30;45(21):6570-80
pubmed: 16716067
Vet Immunol Immunopathol. 2006 Oct 15;113(3-4):305-12
pubmed: 16879874
J Mol Biol. 1992 Jul 20;226(2):507-33
pubmed: 1640463
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5405-10
pubmed: 22431638
Nature. 1992 Apr 30;356(6372):796-8
pubmed: 1574118
J Mol Biol. 1977 May 25;112(3):535-42
pubmed: 875032
Nature. 1987 Nov 19-25;330(6145):256-9
pubmed: 2823150
Anal Biochem. 2013 Dec 1;443(1):113-6
pubmed: 23969013
J Biomol Struct Dyn. 1998 Jun;15(6):1101-13
pubmed: 9669555
Biosci Trends. 2014 Dec;8(6):308-15
pubmed: 25641176
Eur J Immunol. 1990 Jun;20(6):1397-400
pubmed: 2369920
AIDS Res Hum Retroviruses. 2015 May;31(5):525-30
pubmed: 25611551
J Immunol. 1993 Nov 1;151(9):4552-61
pubmed: 8104997
Nature. 1989 Mar 16;338(6212):257-9
pubmed: 2784195
Vet Immunol Immunopathol. 2015 Dec 15;168(3-4):176-83
pubmed: 26429412
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6423-7
pubmed: 2385600
Anim Genet. 2009 Aug;40(4):468-78
pubmed: 19392823
J Immunol. 2019 Feb 1;202(3):799-804
pubmed: 30593536
Immunogenetics. 2018 Apr;70(4):209-222
pubmed: 29052750
Anim Genet. 2010 Aug;41(4):428-32
pubmed: 20121817
Science. 1989 Aug 18;245(4919):743-6
pubmed: 2549633
J Immunol. 1992 May 15;148(10):3195-201
pubmed: 1578144
Front Immunol. 2019 Apr 02;10:618
pubmed: 31001252
Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1166-71
pubmed: 20080564
BMC Vet Res. 2016 Oct 7;12(1):222
pubmed: 27717346
Immunology. 1996 Mar;87(3):500-12
pubmed: 8778040
Scand J Immunol. 2004 Jun;59(6):582-91
pubmed: 15182254
Nature. 2019 Oct;574(7778):353-358
pubmed: 31619795
J Infect Dis. 2009 May 1;199(9):1327-34
pubmed: 19301975
J Pharmacol Sci. 2011;115(2):112-4
pubmed: 21258171
PLoS One. 2012;7(6):e38491
pubmed: 22675567
Vet Immunol Immunopathol. 2012 Aug 15;148(3-4):252-9
pubmed: 22640570
Mol Biol Rep. 2011 Mar;38(3):1621-8
pubmed: 20927596
Anim Biotechnol. 2018 Jul 3;29(3):227-233
pubmed: 29035142
Anim Genet. 2014 Dec;45(6):791-8
pubmed: 25118109
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10799-804
pubmed: 11535811
Lab Anim. 2015 Jan;49(1):65-70
pubmed: 25341543
Pathogens. 2018 May 29;7(2):
pubmed: 29843476
PLoS One. 2016 Oct 19;11(10):e0164995
pubmed: 27760184